APA (7th ed.) Citation

Ding, Z., Sun, S., Wang, X., Yang, X., Shi, W., Huang, X., . . . Lu, X. (2023). Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression. Journal of Hematology & Oncology, 16(1), 1. https://doi.org/10.1186/s13045-023-01507-4

Chicago Style (17th ed.) Citation

Ding, Ziqiang, et al. "Nanobody-based Trispecific T Cell Engager (Nb-TriTE) Enhances Therapeutic Efficacy by Overcoming Tumor-mediated Immunosuppression." Journal of Hematology & Oncology 16, no. 1 (2023): 1. https://doi.org/10.1186/s13045-023-01507-4.

MLA (9th ed.) Citation

Ding, Ziqiang, et al. "Nanobody-based Trispecific T Cell Engager (Nb-TriTE) Enhances Therapeutic Efficacy by Overcoming Tumor-mediated Immunosuppression." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s13045-023-01507-4.